WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 12th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences. The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2014. The event will take place October 8-9, 2013 at the Palace Hotel in San Francisco, California.
“We have an incredibly exciting slate of companies lined up for this year’s BIO Investor Forum, with more than 100 companies already scheduled to present,” said Alan Eisenberg, Executive Vice President, Emerging Companies & Business Development at BIO. “Early investor registrations are currently up 33 percent for this year’s BIO Investor Forum, reflecting greatly increased investor interest in the biotech sector.”
Companies were chosen through a competitive screening process with input from BIO and the event’s advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech and pharmaceutical companies.
The following companies will present at the 12th Annual BIO Investor Forum:
Private:
Alios
BioPharma
Altheus
Therapeutics
Ambrx,
Inc.
AM-Pharma
Holding BV
Aquinox
Pharmaceuticals Inc.
Asuragen,
Inc.
Auspex
Pharmaceuticals, Inc.
Bellicum
Pharmaceuticals
BioCrea
Blueprint
Medicines
Cerecor,
Inc.
ContraFect
Corp
CytomX
Therapeutics
Dicerna
Pharmaceuticals
EGEN,
Inc.
Eleison
Pharmaceuticals LLC
Elusys
Therapeutics
Fate
Therapeutics, Inc.
Forma
Therapeutics
Generon
(Shanghai) Corp. Ltd
Hua
Medicine
Igenica
Immune
Design Co.
Jennerex
Biotherapeutics
KineMed
Labrys
Biologics, Inc.
MabVax
Therapeutics
MaxCyte,
Inc.
Mirna
Therapeutics
Opsona
Therapeutics
OxThera
AB
Polynoma
LLC
Probiodrug
AG
Protagonist
Therapeutics
Proteon
Therapeutics
S1
Biopharma
Spring
Bank Pharmaceuticals
Syndax
Pharmaceuticals
Theraclone
Sciences, Inc.
TissueGene
Vaccinex
Versartis
Vivaldi
Biosciences, Inc.
Zafgen
Zymeworks
Public:
Ambit
Biosciences
Atossa
Genetics
Benitec
Ltd.
Bio-Path
Holdings
Catalyst
Pharmaceutical Partners, Inc.
CG
Pharmaceuticals, Inc.
Cipher
Pharmaceuticals Ltd.
Conatus
Pharmaceuticals, Inc.
Critical
Outcome Technologies
diaDexus
Galena
BioPharma, Inc.
Genesis
Biopharma
GensPera,
Inc.
Heat
Biologics
Horizon
Pharma
Innovus
Pharma
International
Stem Cell Corp.
La
Jolla Pharmaceutical Company
Mast
Therapeutics
Neostem
Ocera
Therapeutics, Inc.
OncoMed
Pharmaceuticals
OncoSec
OxiGENE,
Inc.
Palatin
Technologies
Patrys
Ltd.
Resverlogix
RXi
Pharmaceuticals
Sernova
Corp
Sophiris
Bio
Therapeutics
MD
ZIOPHARM
Oncology Inc.
In addition, the 12th annual BIO Investor Forum will again host Discovery Track presentations, which focus on companies that have raised less than $25M to date in seed or Series A financing rounds. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Discovery Track:
Altravax
America
Stem Cell
Anthrocell
Applied
Integrin Sciences
Armour
Therapeutics
BiologicsMD
DiscoveryBioMed,
Inc.
DLVR
Therapeutics
EicOsis, LLC
FPRT
Bio
Gemmus
Pharma
GeneCentric
Diagnostics
ImmunGene,
Inc.
INanoBio
Kala
Pharmaceuticals
Leading
BioSciences
Maverix
Biomics
Max
BioPharma
NovelMed
Therapeutics
Numab
AG
RECARDIO
ScarX
Therapeutics
Sensorion
Pharmaceuticals
Sialix,
Inc.
SironRX
Therapeutics
Talon
Pharmaceutical Services
TheraVasc
Vascular
Pharmaceuticals
viDA
Therapeutics
Viking
Therapeutics
New presenters are continuously being added. For updates on the list of presenting companies, please visit here. If you are interested in becoming a presenter, please submit an application here.
The BIO Investor Forum is the must-attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in life sciences. BIO One-on-One Partnering™ will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.
BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including our Local Co-Host BayBio and Supporting Banks: Canaccord Genuity, Piper Jaffray and Roth Capital Partners. BIO Double Helix and Helix Sponsors include AbbVie, Amgen, Baxter, Janssen, and Merck. Conference supporters include Blaise Group International, Bristol-Myers Squibb, Chubb, Dectiva, Dentons, Fenwick & West LLP, Knobbe Martens, LaVoie Group, MacDougall Biomedical Communications and SecureDocs.
To learn more about the BIO Investor Forum, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
BIO
Investor Forum
October 8-9, 2013
San Francisco, CA
BIO
IPCC Conference
November 6-8, 2013
Washington, DC
BIO
Convention in China
November 11-13, 2013
Beijing, China
Pacific
Rim Summit on Industrial Biotechnology & Bioenergy
December
8-11, 2013
San Diego, CA
BIO
CEO & Investor Conference
February 10–11, 2014
New
York, NY
BIO
Asia International Conference
April 8-9, 2014
Tokyo, Japan
BIO
International Convention
June 23-26, 2014
San Diego, CA